| # | % | |||||
|---|---|---|---|---|---|---|
| 1 | ZAFGEN INC COM | 600 | 24,000 | 0.00% | ||
| 2 | Codexis Inc Com | 10,000 | 46,000 | 0.00% | ||
| 3 | VERASTEM INC | 20,900 | 213,000 | 0.02% | ||
| 4 | RAPTOR PHARMACEUTICAL CORP | 30,000 | 326,000 | 0.02% | ||
| 5 | XOMA CORP DEL | 177,200 | 645,000 | 0.05% | ||
| 6 | TELEFLEX INC | 5,800 | 701,000 | 0.05% | ||
| 7 | MEDIDATA SOLUTIONS INC | 18,900 | 927,000 | 0.07% | ||
| 8 | FEI COMPANY | 14,800 | 1,130,000 | 0.09% | ||
| 9 | PACIRA PHARMACEUTICALS INC | 13,300 | 1,182,000 | 0.09% | ||
| 10 | LOXO ONCOLOGY INC COM | 114,600 | 1,427,000 | 0.11% | ||
| 11 | AVALANCHE BIOTECHNOLOGIES IN | 37,400 | 1,515,000 | 0.11% | ||
| 12 | INFINITY PHARMACEUTICALS INC | 112,600 | 1,574,000 | 0.12% | ||
| 13 | TANDEM DIABETES CARE INC COM | 129,700 | 1,637,000 | 0.12% | ||
| 14 | IMMUNE DESIGN CORP | 81,957 | 1,730,000 | 0.13% | ||
| 15 | INSMED INC | 88,600 | 1,843,000 | 0.14% | ||
| 16 | ATHENA HEALTH INC. | 16,300 | 1,946,000 | 0.15% | ||
| 17 | REGULUS THERAPEUTICS INC COM | 116,000 | 1,965,000 | 0.15% | ||
| 18 | SAGE THERAPEUTICS INC | 40,200 | 2,019,000 | 0.15% | ||
| 19 | INCONTACT INC | 193,300 | 2,107,000 | 0.16% | ||
| 20 | ONCOMED PHARMACEUTICALS INC COM | 85,100 | 2,194,000 | 0.17% | ||
| 21 | UNIQURE NV | 90,500 | 2,201,000 | 0.17% | ||
| 22 | DBV TECHNOLOGIES S A | 96,400 | 2,252,000 | 0.17% | ||
| 23 | TG THERAPEUTICS INC COM | 183,000 | 2,833,000 | 0.21% | ||
| 24 | DYNAVAX TECHNOLOGIES CORP | 127,400 | 2,858,000 | 0.22% | ||
| 25 | NATUS MEDICAL INC. | 75,000 | 2,960,000 | 0.22% | ||
| 26 | REPLIGEN CORP COM | 99,400 | 3,018,000 | 0.23% | ||
| 27 | GW PHARMACEUTICALS PLC | 33,500 | 3,053,000 | 0.23% | ||
| 28 | ATRICURE INC | 152,300 | 3,121,000 | 0.23% | ||
| 29 | ASPEN TECHNOLOGY COM USD0.10 | 83,000 | 3,195,000 | 0.24% | ||
| 30 | ACCELERON PHARMA INC | 87,100 | 3,315,000 | 0.25% | ||
| 31 | CARDIOVASCULAR SYS INC DEL COM | 86,000 | 3,357,000 | 0.25% | ||
| 32 | ACCURAY INCORPORATED COM | 364,600 | 3,391,000 | 0.26% | ||
| 33 | DICERNA PHARMACEUTICALS INC | 142,100 | 3,415,000 | 0.26% | ||
| 34 | SAREPTA THERAPEUTICS INC | 259,100 | 3,441,000 | 0.26% | ||
| 35 | SUPERNUS PHARMACEUTICALS INC | 286,600 | 3,465,000 | 0.26% | ||
| 36 | Esperion Therapeutics Inc | 39,000 | 3,611,000 | 0.27% | ||
| 37 | XENCOR INC COM | 258,100 | 3,954,000 | 0.30% | ||
| 38 | APPLIED GENETIC TECHNOL CORP | 205,500 | 4,108,000 | 0.31% | ||
| 39 | ULTRAGENYX PHARMACEUTICAL INC COM | 69,000 | 4,284,000 | 0.32% | ||
| 40 | Franklin Covey Co | 224,964 | 4,333,000 | 0.33% | ||
| 41 | ALNYLAM PHARMACEUTICALS INC | 41,900 | 4,375,000 | 0.33% | ||
| 42 | CERNER CORP | 60,100 | 4,403,000 | 0.33% | ||
| 43 | BIOMARIN PHARMACEUTICAL INC | 40,100 | 4,997,000 | 0.38% | ||
| 44 | TESARO INCORPORATED | 87,700 | 5,034,000 | 0.38% | ||
| 45 | CEMPRA INC | 153,800 | 5,277,000 | 0.40% | ||
| 46 | NEUROCRINE BIOSCIE COM USD0.001 | 137,800 | 5,472,000 | 0.41% | ||
| 47 | COSTAMARE INC | 360,200 | 6,343,000 | 0.48% | ||
| 48 | QUANTA SVCS INC | 232,800 | 6,642,000 | 0.50% | ||
| 49 | OCEANEERING INTL INC | 129,700 | 6,995,000 | 0.53% | ||
| 50 | SANGAMO THERAPEUTICS INCORPORATED | 482,500 | 7,566,000 | 0.57% |
Portfolio data is normalized using SEC Form 13F filings, including the Original 13F-HR (0001442891-15-000004, filed 2015.05.14).
From 2023-01-03 onward, the SEC requires values to be reported in nearest dollars. Earlier filings reported values in thousands; therefore, positions shown as $0 in older filings may represent actual values between $0–$999.
